Literature DB >> 29223603

Factors predicting quality of life and societal participation after survival of a cardiac arrest: A prognostic longitudinal cohort study.

Daan Verberne1, Véronique Moulaert2, Jeanine Verbunt3, Caroline van Heugten4.   

Abstract

AIM: For those patients who suffer unfavourable outcome after survival of cardiac arrest, it is important to know whether this can be predicted at an early stage. Support can subsequently be provided. This study aimed to identify early prognostic factors of quality of life (QOL) and societal participation at one year post-cardiac arrest.
METHODS: The design was a prospective longitudinal cohort study following cardiac arrest survivors up to one year. Prognostic personal, injury-related, function-related and subjective outcome factors were selected and entered into a hierarchical regression model to assess whether they were predictive of QOL and societal participation at one year post-cardiac arrest.
RESULTS: Hundred and ten cardiac arrest survivors were included. Not having a partner, more functional limitations (at two weeks) and cognitive complaints were significantly predictive of lower physical QOL, while higher levels of anxiety and depression symptoms (at three months) were significant predictors of mental QOL. A neurological history and higher levels of anxiety and depression symptoms were significantly predictive of lower brain injury-specific QOL. Societal participation was only predicted by premorbid functioning.
CONCLUSION: This study identified prognostic factors of QOL and societal participation one year after survival of cardiac arrest. Screening of these factors in early stages can identify those survivors with possibly unfavourable QOL at one year post cardiac arrest. For those survivors, preventive and targeted interventions may be offered.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Predictors; Quality of life; Societal participation

Mesh:

Year:  2017        PMID: 29223603     DOI: 10.1016/j.resuscitation.2017.11.069

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  5 in total

1.  Neuroprotection of NSC Therapy is Superior to Glibenclamide in Cardiac Arrest-Induced Brain Injury via Neuroinflammation Regulation.

Authors:  Zhuoran Wang; Shuai Zhang; Jian Du; Brittany Bolduc Lachance; Songyu Chen; Brian M Polster; Xiaofeng Jia
Journal:  Transl Stroke Res       Date:  2022-08-03       Impact factor: 6.800

2.  European Resuscitation Council and European Society of Intensive Care Medicine guidelines 2021: post-resuscitation care.

Authors:  Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar
Journal:  Intensive Care Med       Date:  2021-03-25       Impact factor: 17.440

3.  One-year longitudinal study of psychological distress and self-assessed health in survivors of out-of-hospital cardiac arrest.

Authors:  Adam Viktorisson; Katharina S Sunnerhagen; Dongni Johansson; Johan Herlitz; Åsa Axelsson
Journal:  BMJ Open       Date:  2019-07-03       Impact factor: 2.692

4.  Estimating the Burden of Stroke: Two-Year Societal Costs and Generic Health-Related Quality of Life of the Restore4Stroke Cohort.

Authors:  Ghislaine van Mastrigt; Caroline van Heugten; Anne Visser-Meily; Leonarda Bremmers; Silvia Evers
Journal:  Int J Environ Res Public Health       Date:  2022-09-05       Impact factor: 4.614

5.  Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2).

Authors:  Erik Blennow Nordström; Gisela Lilja; Susanna Vestberg; Susann Ullén; Hans Friberg; Niklas Nielsen; Katarina Heimburg; Lars Evald; Marco Mion; Magnus Segerström; Anders M Grejs; Thomas Keeble; Hans Kirkegaard; Hanna Ljung; Sofia Rose; Matthew P Wise; Christian Rylander; Johan Undén; Tobias Cronberg
Journal:  BMC Cardiovasc Disord       Date:  2020-10-07       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.